Kezar Life SciencesKZR

13F holders, Q2 2024 (June 30)
1holders
$0.60avg. 13F price*

At the end of Q2 2024, 1 institutions reported holding Kezar Life Sciences Inc. (KZR) in their 13F filings. The largest holder was Catalyst Funds Management Pty Ltd ($11K).

Company
Kezar Life Sciences Inc.
CUSIP
49372L209
Latest filing quarter
Q1 2026

History

Number of 13F holders

01020304050 Q2 2024: 1Q2 2024Q3 2024: 3Q3 2024Q4 2024: 43Q4 2024Q1 2025: 41Q1 2025Q2 2025: 40Q2 2025Q3 2025: 39Q3 2025Q4 2025: 43Q4 2025Q1 2026: 43Q1 2026

Total Exit/New Position Q2 2024

InstitutionsTotal Value
New Positions1$11K
Exits0$0

Ownership 1 holders

Catalyst Funds Management Pty Ltd 0.00% New 18,300 $11K

"% of holder's portfolio" is KZR's weight in each manager's 13F, not the share of Kezar Life Sciences Inc. the manager owns.